(firstQuint)Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382.

 This is a Phase 1 open label, one-sequence, crossover study to evaluate the effect of MEDI0382 on PK and PD of warfarin and esmolol in healthy subjects.

 The safety and tolerability of MEDI0382 in combination with warfarin and esmolol will also be evaluated.

 Following screening, the study consists of 2 5-day inpatient stays followed by outpatient visits.

.

 Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382@highlight

A Phase 1 study to evaluate the effect of MEDI0382 on PK and PD of warfarin and esmolol in healthy subjects.

